Evidence map›Paper›PMID 30714813›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2019

Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism.

Paul G Thomes, Karuna Rasineni, Li Yang, Terrence M Donohue, Jacy L Kubik, Mark A McNiven, Carol A Casey

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Combinatorial Herbal Extracts Alleviate Alcohol-Induced Hepatic Disorders.Plant foods for human nutrition (Dordrecht, Netherlands) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. ProbioticFrontiers in microbiology · 2022
    Article
  14. Article
  15. Autophagy in liver diseases.World journal of hepatology · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Paul G ThomesThe Liver Study Unit, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
Karuna RasineniThe Liver Study Unit, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
Li YangDepartmentof Internal Medicine, Tongji Hospital, Tongji University School of Medicine , Shanghai , China.
Terrence M DonohueThe Liver Study Unit, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
Jacy L KubikThe Liver Study Unit, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
Mark A McNivenDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine , Rochester, Minnesota.
Carol A CaseyThe Liver Study Unit, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
VA Nebraska Western Iowa Health Care System · USCzech Academy of Sciences, Institute of Microbiology · CZMayo Clinic · USTongji Hospital · CNUniversity of Nebraska Medical Center · US

Funding

Regulation of Alcohol-induced Fatty Liver Disease by Lipid Droplet TraffickingRC1AA019032 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CASEY, CAROL A., MC NIVEN, MARK A. · 2009 to 2010
$998k
NIAAA NIH HHS RC1 AA019032
6 · The paper itself

Abstract

We are investigating the changes in hepatic lipid catabolism that contribute to alcohol-induced fatty liver. Following chronic ethanol (EtOH) exposure, abstinence from alcohol resolves steatosis. Here, we investigated the hepatocellular events that lead to this resolution by quantifying specific catabolic parameters that returned to control levels after EtOH was withdrawn. We hypothesized that, after its chronic consumption, EtOH withdrawal reactivates lipid catabolic processes that restore lipostasis. Male Wistar rats were fed control and EtOH liquid diets for 6 wk. Randomly chosen EtOH-fed rats were then fed control diet for 7 days. Liver triglycerides (TG), lipid peroxides, key markers of fatty acid (FA) metabolism, lipophagy, and autophagy were quantified. Compared with controls, EtOH-fed rats had higher hepatic triglycerides, lipid peroxides, and serum free fatty acids (FFA). The latter findings were associated with higher levels of FA transporters (FATP 2, 4, and 5) but lower quantities of peroxisome proliferator-activated receptor-α (PPAR-α), which governs FA oxidation. EtOH-fed animals also had lower nuclear levels of the autophagy-regulating transcription factor EB (TFEB), associated with lower hepatic lipophagy and autophagy. After EtOH-fed rats were refed control diet for 7 days, their serum FFA levels and those of FATPs fell to control (normal) levels, whereas PPAR-α levels rose to normal. Hepatic TG and malondialdehyde levels in EtOH-withdrawn rats declined to near control levels. EtOH withdrawal restored nuclear TFEB content, hepatic lipophagy, and autophagy activity to control levels. EtOH withdrawal reversed aberrant FA metabolism and restored lysosomal function to promote resolution of alcohol-induced fatty liver. NEW & NOTEWORTHY Here, using an animal model, we show mechanisms of reversal of fatty liver and injury following EtOH withdrawal. Our data indicate that reactivation of autophagy and lysosome function through the restoration of transcription factor EB contribute to reversal of fatty liver and injury following EtOH withdrawal.

Indexed as

Fatty Liver, AlcoholicAlcohol AbstinenceAnimalsAutophagyAutophagy-Related ProteinsCentral Nervous System DepressantsCyclic AMP Receptor ProteinEthanolFatty Acid Transport ProteinsHepatocytesLiver RegenerationPeroxisome Proliferator-Activated ReceptorsRatsRats, WistarAutophagy-Related ProteinsCentral Nervous System DepressantsCyclic AMP Receptor ProteinEthanolFatty Acid Transport ProteinsPeroxisome Proliferator-Activated Receptorsethanolfatty acidoxidant stresssteatosisTFEB

Identifiers

PMID30714813
PMCPMC6957361
OpenAlexW2914100384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.